TREM2 and metabolic dysfunction-associated steatotic liver disease: TREM2+ macrophages have been well reported in the liver, where they are protective against non-alcoholic fatty liver disease (Dou et al., 2016; Hou et al., 2021; Jaitin et al., 2019; Xiong et al., 2019).